ALLEGRA

LOE Approaching

fexofenadine hydrochloride

NDAORALCAPSULE
Approved
Jul 1996
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
8

Clinical Trials (5)

NCT05720455Phase 4Completed

Study to Assess Safety and Efficacy of Fexofenadine Hydrochloride (HCL) + Pseudoephedrine HCL Fixed Dose Combination in Indian Male and Female Participants With Allergic Rhinitis (AR) Who Are 12 Years and Above

Started Jun 2025
203 enrolled
Rhinitis Allergic
NCT01306721Phase 3Completed

Fexofenadine HCL - Pseudoephedrine HCL Combination Versus Allegra in Patients With Seasonal Allergic Rhinitis

Started Feb 2011
520 enrolled
Rhinitis Seasonal
NCT01244230Phase 2/3Completed

Safety, Efficacy and Pharmacokinetic Study of Allegra in Pediatric Patients With Atopic Dermatitis (AD)

Started Nov 2010
100 enrolled
Atopic Dermatitis
NCT01244217Phase 2/3Completed

Safety, Efficacy and Pharmacokinetic Study of Allegra in Pediatric Patients With Perennial Allergic Rhinitis (PAR)

Started Oct 2010
100 enrolled
Rhinitis Perennial
NCT01033396Phase 2Completed

The Effect Of PF-03654764 +/- Allegra On Symptoms Of Allergic Rhinitis

Started Jan 2010
64 enrolled
Allergic Rhinitis